Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M722Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M24.8EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)29.3Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book3.010-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.9PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M4,700,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IHE

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

IHE is held by these investors:

IHE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rapps, MichaelDirector, Director or Senior Officer of 10% Securi 2017-01-16Buy1,200$9.481520.25view
Gridley, Anthony RonaldSenior Officer 2017-01-16Sell1,800$16.94806.73view
Dinwoodie, Tyler Wayne PaulSenior Officer 2017-01-16Buy4,000$0.1790252.94view
Brown, Mark ThomasDirector 2017-01-16Sell29,300$1.3611194.12view
Bebek, IvanDirector 2017-01-16Buy8,990$3.384444.38view
smith, laurie james10% Security Holder, Director, Senior Officer 2017-01-16Buy7,500$0.4137363.41view
MEHR, JEFFREYSenior Officer 2017-01-13Sell50,000$27.91450.34view
Squibb, Geoffrey WayneDirector 2017-01-13Buy267$6.272349.76view
Smith, DavidSenior Officer 2017-01-13Sell15,000$60.38154.39view
Rowlands, William BruceDirector, Senior Officer 2017-01-13Buy20,000$0.15102300view

Quarterly/Annual Reports about IHE:

    News about IHE:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Analysts’ Ratings and Recommendations for Bristol-Myers Squibb Apr 27 2017
    Why medical device stocks may rise if Obamacare is repealed Apr 24 2017
    Why some investors aren't thrilled about Becton Dickinson buying C.R. Bard Apr 24 2017
    Stocks soar after French elections ahead of busiest earnings week in 10 years Apr 24 2017
    How Will Eli Lilly’s Alimta and Other Oncology Products Perform? Apr 21 2017
    Johnson & Johnson’s Pharmaceuticals Segment’s 1Q17 Earnings Apr 21 2017
    Lackluster J&J Q1 Pushes Healthcare ETFs Down Apr 19 2017
    The Larger Aims of Obamacare: An Overview Apr 11 2017
    The Hybrid US Healthcare System: An Overview Apr 11 2017
    There Is Value To Be Had With The Right Healthcare ETFs Apr 05 2017
    There's Value in Healthcare ETFs Apr 04 2017
    What’s Pfizer’s Financial Guidance for 2017? Apr 04 2017
    What Wall Street Analysts Recommend for Merck Mar 29 2017
    Should You Buy Pharma ETFs Now? Mar 15 2017
    Johnson & Johnson’s Business Segment Performance Mar 13 2017
    Why Health Care Is The Top Sector Of 2017 Mar 08 2017
    Analysts Scratch Their Heads Over Trump Drug Price Tweet Mar 07 2017
    Trump Tweets And Drug Stocks Fall Mar 07 2017
    Healthcare ETFs in Focus on Obamacare Replacement Plan Mar 07 2017
    Trump's Latest Drug Pricing Tweet Hits Biotech Stocks Mar 07 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)